Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.43 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.42 |
| ▸ | TGM2 | P21980 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | KRAS | P01116 | 5/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 4/20 | 0.39 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23679647 | 0.89 | FUT5 (0.47) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL20327589 | 0.85 | FUT5 (0.50) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL23679601 | 0.83 | POLB (0.47) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL20327591 | 0.83 | FUT5 (0.47) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL29324484 | 0.82 | TAS1R3 (0.53) | FUT5P2RY2P2RY4P2RY6TAS1R3 | |
| SCHEMBL20782763 | 0.81 | POLB (0.58) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL22381883 | 0.81 | FUT5 (0.53) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL20327581 | 0.80 | FUT5 (0.48) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL23679395 | 0.80 | POLB (0.49) | FUT5P2RY2P2RY4P2RY6POLB | |
| SCHEMBL21417495 | 0.79 | POLB (0.59) | FUT5P2RY2P2RY4P2RY6POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854799-A1 | CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION | Shanghai de Novo Pharmatech Co., Ltd. (CN) | 2021-07-28 | — | — | EP | disclosed |